Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Unilateral Stenting Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction

NCT02649712 is registered in ClinicalTrials.gov with Xuzhou Central Hospital as lead sponsor.

NCT NCT02649712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02649712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Unilateral Stenting Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction
Lead sponsor
Xuzhou Central Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 20, 2016
Completion date
October 31, 2018
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cholangiocarcinoma, gallbladder carcinoma, hepatocellular carcinoma